| Name | Title | Contact Details |
|---|
Tremont Strategies Group is a full service government affairs consulting firm offering a wide range of practices and committed to offering the highest quality service to its clients. Our firm specializes in executing complex, multi-faceted campaigns by utilizing a comprehensive approach to engage stakeholders, policymakers and the general public in order to educate and advocate for our client`s position. With decades of experience in the public and private sectors, we offer in-depth analysis on policy matters and proposals before state and federal government. Our team provides the expertise and entrepreneurial creativity needed to build successful comprehensive public affairs strategies.
Price Forbes is an independent insurance broker established in 1893 and headquartered in London. As part of Ardonagh Specialty, it is recognized as a leading broker in the London market. The company has a global presence, with offices worldwide, and specializes in wholesale insurance broking, focusing on complex risk management solutions for large multinational companies. The services offered by Price Forbes include specialist insurance broking, risk management, and reinsurance solutions through its division, Price Forbes Re. This division provides tailored reinsurance broking, capital solutions, and strategic advisory services, utilizing analytics to meet client needs. Price Forbes also has a strong presence in Africa, with operations in South Africa and partnerships across sub-Saharan Africa. In addition to its business activities, Price Forbes is committed to community involvement through the Ardonagh Community Trust, supporting charitable initiatives and contributing over £1.5 million to various causes.
Landscape Forms is the industrys premier global brand of outdoor furniture, LED lighting and accessories. Since its founding in 1969 Landscape Forms has earned a reputation for excellent design, high quality products and exceptional service. The Landscape Forms U.S. headquarters and manufacturing facility is located in Kalamazoo, Michigan with sales representatives throughout North America, the United Kingdom, Southern Europe, the United Arab Emirates and Asia. Landscape Forms collaborates with renowned industrial designers and consultancies, landscape architects, and architects to design and develop integrated collections of products that address emerging needs and help create a sense of place. The company has an installed base of products around the world. Clients include municipalities, transit centers, corporate, college and health care campuses; and familiar brand leaders such as Boeing, Cisco Systems, Disney, Sprint, American Airlines, Herman Miller and Nike. Landscape Forms was recently named by the Wall Street Journal as one of the Top 15 Small Workplaces in the US.
We are an OEM manufacturer of linear actuators and lifting columns, located in the Greater Grand Rapids area! Our parents company, Jiecang Linear Motion Technology Co.,Ltd was established in 2000 in Xinchang, China. Due to their high standards, their products quickly became globally respected for use in medical and home care equipment. With a large customer base in the United States, they found it necessary to purchase a facility locally which happened in 2018.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.